In addition, the patient tested positive for ANA, a finding observed in approximately 27.8% of patients with primary immune-mediated TTP, although it does not necessarily indicate a currently coexisting connective tissue disease. This evidence concerns the gene BTG3 and thrombotic thrombocytopenic purpura.